Shares of Avidity Biosciences RNA rose more than 12% on Wednesday after the company announced that it is expanding its current RNA-based pipeline of rare muscle disorders to explore a new therapeutic ...

The "North America RNA Therapeutics Market, By Country, Competition, Forecast & Opportunities, 2019-2029F" report has been ...

Zymo’s Quick DNA/RNA Viral MagBead Kit was automated using Analytik Jena’s Cybio FeliX pipetting robot. The CyBio FeliX ...

The company is developing what he calls "biological software," where AI compilers translate specified behaviors into RNA ...

Most people don't enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such as those made from messenger RNA (mRNA), that can be sprayed and inhaled. A ...

Compared to DNA sequencing alone, concurrent DNA and RNA sequencing revealed more clinically actionable variants in NSCLC.

Innovative urinary miRNA profiling shows potential for early pancreatic cancer detection, with high accuracy and sensitivity, ...

Cancer has a high death rate with delayed diagnosis of the disease being one of the main reasons for its fatality. Early ...

CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and ...

Tazeen Ahmad, an analyst from Bank of America Securities, maintained the Buy rating on Avidity Biosciences (RNA – Research Report). The ...

Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...

Nearly three decades later, drug makers have developed six approved small interfering RNA (siRNA) therapeutics in the ...